Effects of Sulforaphane Supplementation on Athletic Performance

NCT ID: NCT07343518

Last Updated: 2026-01-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-01-02

Study Completion Date

2026-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Considering the promising effects observed and the scarce and incipient scientific background of SFN in sports, the present study aims to evaluate the effects of SFN supplementation on fatigue, EIMD and recovery in trained individuals. In particular, outcomes such as time to exhaustion (TTE), and perceptual questionnaires of muscle soreness, recovery, and fatigue will be assessed, aiming to explore the effectiveness of SFN.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Nutrition Sports

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Participants Investigators
Both participants and investigator will be blinded to the experimental conditions. Both placebo and supplementation will have the same appearence. Only the outcome assessor will know the assigned sequence to each participant

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sulforaphane

Sulforaphane supplementation (Nomio)

Group Type EXPERIMENTAL

Fatigue protocol

Intervention Type OTHER

Fatigue protocol comprising 6 sets of 30 seconds at 120% of velocity of maximal oxygen consumption

Placebo

Placebo intervention

Group Type PLACEBO_COMPARATOR

Fatigue protocol

Intervention Type OTHER

Fatigue protocol comprising 6 sets of 30 seconds at 120% of velocity of maximal oxygen consumption

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Fatigue protocol

Fatigue protocol comprising 6 sets of 30 seconds at 120% of velocity of maximal oxygen consumption

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Physically active individuals (engaging in exercise 3 or more times per week)

Exclusion Criteria

* Individuals that experience musculoskeletal injuries or have experienced in the past 3 months
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Maia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Filipe Silvano Pinto Maia

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SFN_001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.